Skip to content
RDL Network logo
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: Strategies to overcome drug resistance development — De Clercq Erik (1996) | RDL Network